| 1. |
Guarascio AJ, Ray SM, Finch CK, et al. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res, 2013, 5: 235-245.
|
| 2. |
王夢瑩, 劉冬靜, 黃輝, 等. 慢性阻塞性肺疾病遺傳易感性研究進展. 中華流行病學雜志, 2016, 37(12): 1678-1682.
|
| 3. |
Watz H, Tetzlaff K, Wouters EF, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med, 2016, 4(5): 390-398.
|
| 4. |
Pascoe S, Locantore N, Dransfield MT, et al. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med, 2015, 3(6): 435-442.
|
| 5. |
Negewo NA, McDonald VM, Baines KJ, et al. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Int J Chron Obstruct Pulmon Dis, 2016, 11: 1494-1504.
|
| 6. |
Zanini A, Cherubino F, Zampogna E, et al. Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 2015, 10: 1155-1161.
|
| 7. |
柳威, 陳榮昌. 慢性阻塞性肺疾病誘導痰細胞分類特點及其與治療反應性的相關性分析. 中國呼吸與危重監護雜志, 2016, 15(6): 537-541.
|
| 8. |
Kreindler JL, Watkins ML, Lettis S, et al. Effect of inhaled corticosteroids on blood eosinophil count in steroid-na?ve patients with COPD. Br Med J Open Respir Res, 2016, 3(1): e000151.
|
| 9. |
康閃閃, 何晟, 朱恬華, 等. 慢性阻塞性肺疾病急性加重期治療前后誘導痰細胞分類、血 ECP 變化的臨床分析. 中國臨床醫生, 2014, 42(2): 24-26.
|
| 10. |
曾強林, 王曉明, 李珊娜, 等. 慢性阻塞性肺疾病急性加重患者血嗜酸粒細胞增高的發生情況及臨床特征. 中華醫學雜志, 2017, 97(40): 3166-3170.
|
| 11. |
Zysman M, Deslee G, Caillaud D, et al. Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD. Int J Chron Obstruct Pulmon Dis, 2017, 12: 1819-1824.
|
| 12. |
Duman D, Aksoy E, Agca MC, et al. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia. Int J Chron Obstruct Pulmon Dis, 2015, 10: 2469-2478.
|
| 13. |
DiSantostefano RL, Hinds D, Le HV, et al. Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort. Respir Med, 2016, 112: 88-96.
|
| 14. |
Agusti A, Edwards LD, Celli B, et al. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J, 2013, 42(3): 636-646.
|
| 15. |
Eltboli O, Bafadhel M, Hollins F, et al. COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils. BMC Pulm Med, 2014, 14: 112.
|
| 16. |
Ernst P, Saad N, Suissa S. Inhaled corticosteroids in COPD: the clinical evidence. Eur Respir J, 2015, 45(2): 525-537.
|
| 17. |
Brightling CE. Biomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary disease. Ann Am Thorac Soc, 2013, 10(Suppl): S214-S219.
|
| 18. |
Wedzicha JA, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society Guideline. Eur Respir J, 2017, 49(3): pii: 1600791.
|
| 19. |
Tworek D, Majewski S, Szewczyk K, et al. The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD. Respir Res, 2018, 19(1): 108.
|
| 20. |
Gunen H, Gulbas G, In E, et al. Venous thromboemboli and exacerbations of COPD. Eur Respir J, 2010, 35(6): 1243-1248.
|
| 21. |
Bertoletti L, Quenet S, Laporte S, et al. Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry. Respir Res, 2013, 14: 75.
|
| 22. |
McKeever TM, Hearson G, Housley G, et al. Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study. Thorax, 2016, 71(3): 210-215.
|
| 23. |
何浪濤, 何奕濤. 嗜酸性粒細胞對 AECOPD 預后的評估價值. 臨床肺科雜志, 2016, 21(6): 1015-1017.
|
| 24. |
Vedel-Krogh S, Nielsen SF, Lange P, et al. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen General Population Study. Am J Respir Crit Care Med, 2016, 193(9): 965-974.
|
| 25. |
Kang HS, Rhee CK, Kim SK, et al. Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2467-2473.
|
| 26. |
Cheng SL, Lin CH. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2341-2348.
|
| 27. |
Bafadhel M, Greening NJ, Harvey-Dunstan TC, et al. Blood eosinophils and outcomes in severe hospitalized exacerbations of COPD. Chest, 2016, 150(2): 320-328.
|
| 28. |
Rogliani P, Matera MG, Puxeddu E, et al. Emerging biological therapies for treating chronic obstructive pulmonary disease: a pairwise and network meta-analysis. Pulm Pharmacol Ther, 2018, 50: 28-37.
|
1/5
WeChat